Product Information
| Concentration | 0.2 mg/mL |
| Applications | ELISA, WB, Dot blot |
| Host Species | Goat |
| Species Reactivity | Human |
| Physical State | Liquid |
| Suggested Dilution Range | 1:2000-1:10,000 for western blotting with ECL substrates 1:1000-1:20,000 for ELISA and Western blotting with chromogenic substrates |
| Purity | The antibody was purified from antisera by immunoaffinity chromatography using antigens coupled to agarose beads. |
| Storage Buffer | 0.01 M Sodium phosphate, 0.25 M NaCl, 50% glycerol, 3 mg/ml BSA, pH 7.6. |
| Storage Instructions | Store at -20°C. Stable for one year after shipment. |
| Stabilizer | 3 mg/ml BSA |
| Clonality | Polyclonal |
| RRID | AB_2890979 |
| Note | This product is for research use only,not for diagnostic or therapeutic use. |
Publications
| Title |
|---|
Nat Immunol Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch. |
J Exp Med Japanese encephalitis virus-primed CD8+ T cells prevent antibody-dependent enhancement of Zika virus pathogenesis. |
Virol Sin Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China. |
PLoS Pathog Pair combinations of human monoclonal antibodies fully protected mice against bunyavirus SFTSV lethal challenge |
EBioMedicine Novel Japanese encephalitis virus NS1-based vaccine: Truncated NS1 fused with E. coli heat labile enterotoxin B subunit. |
Front Microbiol A human monoclonal antibody isolated from Japanese encephalitis virus vaccine-vaccinated volunteer neutralizing various flaviviruses |